Another marker was EphA2, an oncogenic receptor tyrosine kinase linked to poor overall survival in NSCLC [29, 30, 31] and involved in EGFR as well as VEGFR2 signaling in NSCLC [32, 33, 34]. The gene discussed is EPHA2; the disease is non-small cell lung carcinoma.